丙种球蛋白治疗腺病毒性肺炎临床疗效观察  被引量:2

Observation of Clinical Effect of Gamma Globulin in Treatment of Adenovirus Pneumonia

在线阅读下载全文

作  者:马颖 MA Ying(Department of Pediatrics,Liaocheng People's Hospital,Liaocheng Shandong 252000,China)

机构地区:[1]聊城市人民医院儿科,山东聊城252000

出  处:《中国卫生标准管理》2020年第16期86-88,共3页China Health Standard Management

摘  要:目的分析腺病毒性肺炎患儿应用丙种球蛋白治疗的临床效果。方法本研究将我科临床入选(2015年9月—2019年12月)的100例腺病毒性肺炎患儿运用随机数表法分为对照组和观察组,各50例,对照组行抗病毒治疗,观察组在抗病毒治疗基础上合并丙种球蛋白治疗,比较临床症状改善时间和治疗效果。结果经治疗后对照组和观察组患儿治疗总有效率分别为84.00%、96.00%,差异有统计学意义(P<0.05);发热、肺部啰音、气促、咳嗽等临床症状消失时间观察组均较对照组短(P<0.05)。结论采用丙种球蛋白治疗腺病毒性肺炎临床疗效显著,缩短了发热、肺部啰音、气促、咳嗽等临床症状的消失时间,促进了患者病情的康复,建议推广应用。Objective To analyze the clinical effect of gamma globulin therapy in patients with adenovirus pneumonia.Methods In this study,100 patients with adenoviral pneumonia selected from our department(September 2015-December 2019)were divided into a control group and an observation group by random number table method,50 cases each,and the control group received antiviral treatment.The observation group combined with gamma globulin therapy on the basis of antiviral therapy,and compared the clinical symptom improvement time and treatment effect.Results After treatment,the total effective rates of the patients in the control group and the observation group were 84.00%and 96.00%(P<0.05)respectively;the disappearance time of fever,lung rales,shortness of breath,cough and other clinical symptoms in the observation group was shorter than that in the control group(P<0.05).Conclusion The use of gamma globulin in the treatment of adenoviral pneumonia has a significant clinical effect,shortening the disappearance of clinical symptoms such as fever,lung rales,shortness of breath,and cough,and promoting the recovery of the patient's condition.It is recommended to promote its application.

关 键 词:丙种球蛋白 腺病毒 肺炎 临床症状 抗病毒 治疗效果 

分 类 号:R563[医药卫生—呼吸系统]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象